https://www.selleckchem.com/products/Temsirolimus.html Around 40 % of respondents are uncertain whether they can cope with these. According to the respondents, the well-being and presenteeism of the leaders surveyed has deteriorated in the course of the pandemic outbreak and they appeared to be more often ill at work. Financial and structural measures, the strengthening of social cohesion and explanation were mentioned as coping strategies. The results show an increase in challenges and illustrate interdependent pandemic-related burdens. These are mainly met by overtime and additional effort, especially on the part of leaders. It remains unclear what long-term consequences are to be expected from the burden situation. The results show an increase in challenges and illustrate interdependent pandemic-related burdens. These are mainly met by overtime and additional effort, especially on the part of leaders. It remains unclear what long-term consequences are to be expected from the burden situation.Background COVID-19 has led to a change in care for patients with chronic conditions, involving a transfer of drug administration from an outpatient to a community setting. To investigate patient preferences for treatment settings in the light of the current pandemic. Patients, who prior to the pandemic had attended two different outpatient clinics in a university hospital for their infusions or injections, were interviewed by telephone. The semi-structured interviews were analyzed using qualitative and quantitative methods. Out of 49 patients with either anti-inflammatory or immunoglobulin treatments (response rate 83 %), 24 (49.0 %) switched from subcutaneous (sc) injections in the hospital to the community setting, 18 (36.7 %) from intravenous infusions (iv) in the hospital to sc administration at home and 7 (14.3 %) moved to iv at home. During the pandemic 38 (80.9 %) wanted to continue their treatment at home, but after the pandemic 22 (46.8 %) would opt to go back to th